These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35522785)

  • 1. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer.
    Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M
    Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
    Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
    Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients.
    Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM
    J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial.
    Xie J; Xu F; Zhao Y; Cai G; Lin X; Zhu Q; Lin Q; Yao Y; Xu C; Cai R; Wang S; Tang X; Chen C; Zheng S; Chen M; Chen M; Qian X; Shen C; Li J; Xu H; Xu F; Han Y; Li M; Ou D; Shen KW; Qi WX; Cao L; Huang X; Chen J
    BMJ Open; 2022 Sep; 12(9):e062034. PubMed ID: 36581983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
    Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
    J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy.
    Bochenek-Cibor J; Georgiew F; Goyal S
    Breast J; 2020 Feb; 26(2):176-181. PubMed ID: 31531930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF
    Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
    Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
    Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.
    Wong JS; Uno H; Tramontano AC; Fisher L; Pellegrini CV; Abel GA; Burstein HJ; Chun YS; King TA; Schrag D; Winer E; Bellon JR; Cheney MD; Hardenbergh P; Ho A; Horst KC; Kim JN; Leonard KL; Moran MS; Park CC; Recht A; Soto DE; Shiloh RY; Stinson SF; Snyder KM; Taghian AG; Warren LE; Wright JL; Punglia RS
    JAMA Oncol; 2024 Oct; 10(10):1370-1378. PubMed ID: 39115975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
    Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
    Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy following mastectomy for axillary node-positive breast cancer: indication of chest wall irradiation.
    Ogawa K; Toita T; Kakinohana Y; Adachi G; Nishikuramori Y; Kamada Y; Miyaguni T; Shimabukuro K; Tamaki N; Murayama S
    Oncol Rep; 2000; 7(5):1107-12. PubMed ID: 10948347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.